Viking Therapeutics, Inc

VKTX XNAS • PHARMACEUTICAL PREPARATIONS

Historical Short Interest Share

American Express® Business Gold Card

Earn Up to 200K Membership Rewards® Points

4X on your top 2 spending categories. Transfer to 20+ airline & hotel partners. Terms apply.

Learn More

Market Cap

Short interest (Jul 15)

19.9%

Net Short (Jul 27 ): 0.0%

Borrow Fee

0.25%

↓ 6.8%

Available Shares

700K

↑ 76.3%

Price Chart

Company Overview

Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, and VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype-selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.

Company Info

Exchange: NASDAQ

Industry: PHARMACEUTICAL PREPARATIONS

CIK: 0001607678

Asset Type: CS

Market Data

Market Cap: $4,039,315,319

Employees: 59

Status: Active

Short Interest

Current Borrow Fee 0.25%

Range: 0.25% - 0.25%

Available Shares 700K

Range: 650K - 700K

Recent Changes

Fee Change: ↓ 2.2%

Available Change: ↑ 3.6%

Quick Actions

View Dilution Chart

Add to Watchlist Set Price Alert View Options Chain

Investment Risk

This is not financial advice. All investments carry risk. Do your own research before making investment decisions.

Weekly Research

Get Weekly Super Stonk Alerts

Never miss a squeeze opportunity. Get our weekly analysis of high short interest stocks, AI-discovered gems, and dilution warnings delivered to your inbox.

No spam • Unsubscribe anytime